• Most Popular
  • Most Shared

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

Fri Nov 6, 2009 3:26pm EST
 

WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals,
Inc.(®) (Nasdaq GM: DUSA), a dermatology company that is developing and
marketing Levulan(®) Photodynamic Therapy (PDT) and other products focused on
patients with common skin conditions, announced that Bob Doman, President and
Chief Executive Officer, will present a corporate overview at the Merriman
Curhan Ford Investor Summit 2009 on Tuesday, November 10, 2009 at 10:00 a.m.
ET at the Hotel Sofitel in New York City.  Interested investors can access the
live audio webcast of the presentation at www.dusapharma.com.  An archived
version of the presentation will be available on the DUSA website for 90 days
following the presentation.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc.( ® )is an integrated dermatology pharmaceutical
company focused primarily on the development and marketing of its Levulan(®)
Photodynamic Therapy technology platform, and complementary dermatology
products.  Levulan( )PDT is currently approved for the treatment of Grade 1
and 2 actinic keratoses of the face and scalp.  DUSA also markets other
dermatology products, including ClindaReach(®).  DUSA is researching Levulan
PDT for the treatment of AKs and the prevention of new non-melanoma skin
cancer in chronically immunosuppressed solid organ transplant recipients. 
DUSA is based in Wilmington, Mass. Please visit our web site at
www.dusapharma.com.



SOURCE  DUSA Pharmaceuticals, Inc.

Chad Rubin, +1-646-378-2947, for DUSA Pharmaceuticals


More from Reuters

U.S. Speaker of the House Nancy Pelosi (C) is surrounded by reporters as she walks towards the U.S. House of Representatives chamber to begin the vote on health care reform on Capitol Hill in Washington, March 21, 2010. REUTERS/Larry Downing

Democrats face dubious voters

Democrats in Congress who passed historic legislation to revamp the healthcare system face a new challenge: convincing voters it's a good deal.  Full Article | Video 

Healthcare reform
A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    Afghanistan
    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article 

      Pharmaceuticals